Abstract
Introduction: Thyroid cancer is a malignancy accounting for less than 1% of human malignancies. This study aim was to investigate the effect of Senna tablets (C-Lax®) in increasing the dose of radiation excreted in patients who underwent iodine therapy in the iodine treatment center of Namazi Hospital of Shiraz University of Medical Sciences at discharge time.Methods: In this study, 180 female patients aged 30-50 years old with BMI ranges from 22 to 26 and no history of gastrointestinal diseases, especially gastrointestinal ulcers, constipation, and known intestinal diseases, were included in our study into 6 groups of 30 patients. The first three groups received 100, 150, and 200 mCi radiation respectively, and did not receive C-lax tablets. The second three groups received 100, 150, and 200 mCi radiation respectively, and additionally, received 2 C-lax tablets of Dineh Iran Pvt. Ltd. Results: In all 3 doses studied, more than 50% of reduction in radiation dose at discharge was seen. There is a statistically significant difference between the different doses of iodine intake in each of the two groups. Results show that there is a statistically significant difference between groups with consumption and without consumption of C-Lax tablets in all three doses paired groupsDiscussion and Conclusion: The radiation dose of patients at discharge time has an important effect on both patients and their families' health and thereby it should be taken into consideration. C-lax tablets can significantly reduce the radiation dose of patients at their discharge. This can result in better compliance of patients and decreased expenses for the health system and patients